Publications

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.

Author(s): Barda N, Dagan N, Cohen C, Hernán MA, Lipsitch M, Kohane IS, Reis BY, Balicer RDJournal: LancetPMID: 34756184 October 2021

Many countries are experiencing a resurgence of COVID-19, driven predominantly by the delta (B.1.617.2) variant of SARS-CoV-2. In response, these…

Missing again: US racial and ethnic data for COVID-19 vaccination.

Author(s): Krieger N, Waterman PD, Chen JT, Testa C, Hanage WPJournal: LancetPMID: 33743218 March 2021

Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19.

Author(s): Mina MJ, Peto TE, García-Fiñana M, Semple MG, Buchan IEJournal: LancetPMID: 33609444 February 2021

SARS-CoV-2 serosurveys in low-income and middle-income countries

Author(s): Mugunga JC, Tyagi K, Bernal-Serrano D, Correa N, Iberico M, Kateera F, Leandre F, Murray M, Suffrin JCDJournal: LancetPMID: 33516323 January 2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurveys provide crucial information on previous SARS-CoV-2 infections in communities. These surveys are…

Patient pathways and delays to diagnosis and treatment of tuberculosis in an urban setting in Indonesia

Author(s): Lestari BW, McAllister S, Hadisoemarto PF, Afifah N, Jani ID, Murray M, Van Crevel R, Hill PC, Alisjahbana BJournal: Lancet December 2020

Understanding patient pathways can help align patient preferences and tuberculosis (TB) related services. We investigated patient pathways, and diagnostic and…

US racial and ethnic data for COVID-19 cases: still missing in action.

Author(s): Krieger N, Testa C, Hanage WP, Chen JTJournal: LancetPMID: 33169681 October 2020

On June 4, 2020, the Trump Administration, responding to criticisms regarding the incompleteness of racial and ethnic data for COVID-19…

Scientific consensus on the COVID-19 pandemic: we need to act now.

Author(s): Alwan NA, Burgess RA, Ashworth S, Beale R, Bhadelia N, Bogaert D, Dowd J, Eckerle I, Goldman LR, Greenhalgh T, Gurdasani D, Hamdy A, Hanage WP, Hodcroft EB, Hyde Z, Kellam P, Kelly-Irving M, Krammer F, Lipsitch M, McNally A, McKee M, Nouri A, Pimenta D, Priesemann V, Rutter H, Silver J, Sridhar D, Swanton C, Walensky RP, Yamey G, Ziauddeen HJournal: LancetPMID: 33069277 October 2020

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 35 million people globally, with more than 1 million…